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Abstract
Background: There is little evidence concerning the effect of sevoflurane in outpatient procedural sedation, especially
in children. We hypothesised that the addition of sevoflurane to a sedation regimen improves children’s behaviour
with minimal adverse events.
Methods: This is a randomised, triple-blind clinical trial conducted on an outpatient basis. Participants were 27
healthy children aged 4 to 6 years, who previously refused dental treatment with non-pharmacologic methods.
All participants received oral midazolam (0.5 mg/kg, maximum 20 mg) and oral ketamine (3 mg/kg, maximum
50 mg) and, in addition: Group MK – 100% oxygen; Group MKS – inhalational sevoflurane at a sedative dose
(final expired concentration between 0.3 and 0.4%). Dental appointments were video recorded for assessment
of the children’s sleep patterns, crying, movements, and overall behaviour during the procedure with the Houpt
scale. Intra- and post-operative adverse events were systematically reported. Data were analysed by bivariate
analyses in the IBM SPSS v. 19, at a significance level of 5%.
Results: MK (n = 13) and MKS (n = 14) did not differ regarding the Houpt scores (P > 0.05), but 53.8% of children
in the MK group showed hysterical and continuous crying at the time of the local anaesthesia injection, compared to
7.1% of children in the MKS group (P = 0.01; phi = 0.5). There was a trend toward less crying and movement over time
during the dental appointment in the MKS group (P = 0.48). Minor adverse events were observed in 10 MK children
and 4 MKS children (P = 0.01).
Conclusions: The addition of sevoflurane to oral midazolam-ketamine improved the children’s crying behaviour
during local anaesthetic administration, and did not increase the occurrence of adverse events.
Trial registration: Clinical Trials NCT02284204. Registered 5 October 2014.
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Background
Paediatric sedation outside of the operating room is a
growing theme in the anaesthesiology field. Few new seda-
tives have been launched in the last decade, which sug-
gests the need for further development of new routes and
methods for delivery of existing anaesthetic agents [1].
Sevoflurane, “a near-perfect anaesthetic,” has been used
for procedural sedation in an outpatient basis and in
intensive care units [2]. However, there is little evidence of
its effectiveness and safety in the paediatric population for
a variety of procedures, including color Doppler ultra-
sound examination [3], voiding cystourethrography [4],
gastrointestinal endoscopy [5], placement of central cath-
eter in neonatal intensive care [6], magnetic resonance
imaging [7], and dental treatment [8–13].
In paediatric dentistry, inhalation sedation with sevo-
flurane and nitrous oxide has reached success rates vary-
ing from 80 to 92% [8, 9, 12], which are increased to up
99% when intravenous midazolam and fentanyl are
added as an alternative to general anesthesia [10, 11, 13].
A systematic review concluded that there is a need for
clinical trials on sedation agents for dental treatment
since only the agents that showed some (weak-very
weak) evidence of effectiveness were oral midazolam and
nitrous oxide inhalation [14].
Among the aforementioned studies, there were only 3
clinical trials conducted in the dental setting [9, 10, 12];
however, these studies did not examine the effects of sevo-
flurane as the sole gas inhaled anaesthetic agent (without
nitrous oxide). Additional information is needed to add to
the development of the outpatient sedation technique
with sevoflurane. Thus, we performed this clinical trial
with the aim of assessing the effect of sevoflurane during
dental treatment in children aged 4 to 6 years old. We
hypothesised adding sevoflurane to a sedation regimen




This is a triple-blind, controlled, parallel-group clinical
trial with balanced randomisation (1:1), approved by the
Research Ethics Committee of the Universidade Federal
de Goiás (UFG), Brazil (protocol #307/11). Children’s par-
ents were informed about the study’s aims, procedures,
benefits and risks, and invited to sign the consent form.
This clinical trial was registered in the clinicaltrials.gov
database with the number NCT02284204. Two sedative
regimens were compared: midazolam and ketamine (MK),
and midazolam, ketamine and sevoflurane (MKS). A pilot
study with 10 children tested the operational aspects of
this trial, and no changes in methods were needed after
trial commencement.
Participants screening, consent and preparation
Participants were children referred for dental treatment
requiring sedation in the Dental Sedation Centre (Núcleo
de Estudos em Sedação Odontológica - “NESO”) of the
UFG Dental School. This centre is a community extension
project where a multi-professional team (anaesthesiologist,
paediatrician, paediatric dentist and psychologist) assist
underserved children that need dental sedation to have
their oral rehabilitation. The researchers follow the dental
sedation protocol recommended by international guide-
lines, aiming to provide minimal to moderate sedation
level [15]. The use of ketamine, however, can produce a
dissociative sedation, which is defined as “a trancelike cata-
leptic state induced by the dissociative agent ketamine,
characterized by profound analgesia and amnesia, with
retention of protective airway reflexes, spontaneous respi-
rations, and cardiopulmonary stability” [16].
To be included in this trial, children had to meet the
following inclusion criteria: 4 to 6 years old, American
Society of Anesthesiologists Physical Status I or II, pre-
senting patent airway and effective nasal breathing, need
of a restorative procedure in a lower primary molar, and
negative behaviour in a previous attempt of dental treat-
ment. Exclusion criteria included the following: previous
experience of dental treatment under sedation, or having
completed 7 years at the day of the dental sedation
appointment.
After a child was considered eligible to participate in
this trial and the parent signed the consent form, one of
the researchers that did not take part in the interven-
tions enrolled the child and scheduled the intervention
appointment at the most convenient day for the parent.
The child was then randomly assigned to either the MK
or MKS group. Simple randomisation with a 1:1 alloca-
tion ratio was used. One researcher that did not partici-
pate in the interventions and outcomes assessments
created a computer-generated list through the website
Randomization.com (http://www.randomization.com).
Each child was assigned to a group at the day of the
intervention according to the consecutively numbered
code generated in the list. As only the physicians knew
the codes, they assigned participants to interventions.
Dental sedation facility, personnel and monitoring
The sedation procedures were entirely carried out in an
outpatient clinic, which accommodates open operatories
to support medication administration, dental treatment
and post-anaesthesia recovery.
The sedation team trained to comply with this protocol
were: the paediatrician, one of the three anaesthesiologists,
one of the two paediatric dentists, one dental hygienist
and one observer responsible to monitor appropriate
physiologic parameters.
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The monitoring devices were: Infinity® Delta multipa-
rameter monitor (Drägerwerk AG & Co., Lübeck,
Germany) to assess oxygen saturation, electrocardiog-
raphy, end-tidal carbon dioxide and anaesthetic gas (sevo-
flurane) analysis, and the defibrillator DEA Life400 Futura
(Cmos Drake, Nova Lima, Brazil). Also, there was an on-
site emergency cart that contains age-and size-appropriate
equipment and drugs as recommended to resuscitate a
nonbreathing and unconscious child [15].
Dental sedation procedures
On the day of treatment, children arrived at the clinic to
have their health status and fasting protocols checked,
and then were accompanied by a parent and a trained
observer to a sedative delivery place where the anaes-
thesiologist or paediatrician assessed the child’s vitals,
prepared medications in a disposable syringe, and ad-
ministered the drugs through the oral route: Midazolam
0.5 mg/kg, maximum dose 20 mg (Dormire®, Cristália,
São Paulo, Brazil) and ketamine 3 mg/kg, maximum
dose 50 mg (S+ Ketamin®, Cristália, São Paulo, Brazil).
The observer monitored children’s behaviour and vital
signs from since before sedative administration until
discharge.
After 15 min, the trained observer and the child/parent
dyad went to the place prepared for dental treatment and,
according to the group assigned by the anaesthesiologist,
the child received only oxygen (MK) or a mixture of
oxygen and sevoflurane (MKS) provided through an anaes-
thesia workstation - Fabius® Plus (Drägerwerk AG & Co.,
Lübeck, Germany). The gases were provided through a
mask placed over the nose of the child - Dynomite® Nasal
Hood (Matrx-Parker Instrument, Hatfield, United States of
America) - and analysed using an anaesthetic gas analyzer
- Vamos® (Drägerwerk AG & Co., Lübeck, Germany).
Initially, the child received 100% oxygen at a flow rate of
5 L/min, for 5 min. After this period, if the child was ran-
domised to the MKS Group, sevoflurane was added in an
initial concentration of 0.1%, with a 0.1% increment every
30 s until reaching a final expired concentration between
0.3 and 0.4%. In cases where the child had been rando-
mised to the MK group (without sevoflurane), the anaes-
thesiologist simulated the supply of sevoflurane, but the
child received only 100% oxygen. The gas analyzer screen
was camouflaged by a strategic coverage, allowing the
sevoflurane measures viewed only by the anaesthesiologist.
The anaesthesiologist helped by the observer continuously
monitored oxygen saturation, heart rate, fractional inspired
carbon dioxide and end-tidal carbon dioxide.
After 15 min of placing the nasal mask and supply of
gases, the paediatric dentist began the dental treatment
as previously planned (Fig. 1 - consents to publish this
image were collected from the child’s parents and health
professionals). One certified paediatric dentist performed
dental restorations after local anaesthesia (inferior alveolar
nerve block with lidocaine 2% with epinephrine 1:100,000)
and rubber dam isolation, using non-pharmacological
tecnhiques in addition to the sedatives. A parent stayed
with the child during the whole treatment.
At the end of the dental procedure, the dedicated
observer, child and parent were to the post-anaesthetic
recovery place and the child was monitored until the
discharge criteria were met [15]: Satisfactory and stable
cardiovascular function and airway patency; adequate
state of hydration; child awake or easily arousable, with
intact protective reflexes, can talk and sit up unaided.
Post-operative recommendations (written protocol) were
explained and given to parents/guardians.
The paediatric dentist, the child/parent, the observers
and the data analyst were blinded to the allocation. Only
the anaesthesiologist and the paediatrician knew the
group that each child was assigned to properly manage
any adverse event as needed.
Behaviour assessment
The primary endpoint of this research was to evaluate
the effects of sevoflurane on the behaviour of children
Fig. 1 Sedation of children for dental treatment with sevoflurane
provided through a nasal mask (a) and assessed by an anaesthetic
gas analyser (b). Consents to publish this image were collected from
the child’s parents and health professionals
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aged 4 to 6 years old during dental treatment by com-
paring 2 sedative regimens.
The dental sedation appointment was video recorded
with a digital camera to allow a detailed observation of
children’s behaviour during the dental treatment.
The child’s behaviour was evaluated using the Houpt
scale [17], with an observer blinded to the sedation
group that was previously trained and calibrated. The
Houpt scale is a tool used to assess a child’s behaviour
during dental sedation according to specific categories and
scores including: sleep (1-awake, 2-drowsy, disoriented),
movement (1-violent, 2-continuous, 3-controllable, 4-no
movement), cry (1-hysterical, 2-continuous, 3-intermitent,
4-no cry), and overall behaviour (1-treatment aborted,
2-poor, 3-regular, 4-good, 5-very good, 6-excellent).
This scale has been reported in various paediatric sed-
ation studies and has good psychometric properties
[18, 19]. During the sessions, both groups had the chil-
dren's behaviour evaluated every minute and also in 3
specific moments of the dental treatment: at the time
of anaesthesia; at the time of use of high-speed hand-
piece, and at the end of the treatment. In addition, an
overall assessment of behaviour during the treatment
session was conducted.
A senior researcher with expertise in paediatric dentis-
try trained 4 observers (dental students) to assess the
children’s behaviour in the digital videos in a four-hour
workshop with videos of children that did not take part
in this study. Those observers were not present at the
moment of sedation in order to not smell any eventual
gas (sevoflurane). For calibration, each observer watched
five-minute videos of 3 patients during the clinical
examination and registered a specific score for sleep,
movement, cry and overall behaviour for each minute of
the video. Weighted kappa values were between 0.8 and
0.9 for intra- and inter-examiner agreement.
Adverse events assessment
The secondary endpoint was the occurrence of adverse
events in the perioperative period and in the first 24 h
after dental treatment sessions under sedation.
The World SIVA International Sedation Task Force
proposed a definition that is specific to sedation-related
occurrences: “unexpected and undesirable response(s) to
medication(s) and medical intervention used to facilitate
procedural sedation and analgesia that threaten or cause
patient injury or discomfort” [20]. The Task Force pre-
sented a tool for reporting adverse sedation events. This
tool was used to develop specific forms of possible
adverse events for this research [20].
An observer was responsible for completing the spe-
cific forms for possible adverse events in the intraopera-
tive period and in the 24 h following the dental sedation
appointment (this information was obtained by tele-
phone contact with parents/guardians).
Statistical planning and analysis
Sample size was estimated based on a pilot study of 10
children that were included in the final sample. Diverse
calculations considering 3 different outcomes were per-
formed: occurrence of continuous or hysterical crying
during the procedure (MK = 50.0% and MKS = 0%); oc-
currence of continuous or violent movement during the
procedure (MK = 33.3% and MKS = 0%), and occurrence
of any adverse event in the first 24 h post-operative
period (MK = 83.3% and MKS = 25.0%). For each out-
come, a sample size of 11, 18 or 10 children, respectively,
was established to achieve a probability of 80% to detect a
difference in the level of significance of 5% in a two-tailed
hypothesis test.
Data were analysed using the IBM SPSS version 19.0
(SPSS Inc. Chicago, IL, USA). MK and MKS groups were
compared in terms of the dependent variables including
the child's behaviour (movement, cry, overall), vital signs
(heart rate and oxygen saturation) and occurrence of
adverse events (intraoperative and the first 24 h postop-
erative). Independent variables included the child’s gen-
der, age, weight, dose of oral sedatives, need of physical
restraint, duration of the dental sedation appointment,
heart rate and oxygen saturation.
After testing for data distribution in each continuous
variable, data were analysed through bivariate tests:
Student’s T-Test, Mann-Whitney’s U-Test, Fisher’s
Exact-Test, Pearson’s Chi-Square and Likelihood-Ratio
Chi-Square. The significance level was set at P < 0.05.
Results
From a total of 43 children accessed for eligibility during
2014, 27 children (nine girls and 18 boys) with a mean
age 4.9 years old (standard deviation “SD” 0.8) met the
inclusion criteria and received the interventions. Such
children were randomised as follows: 13 children (10
boys) for the MK Group and 14 children (8 boys) for the
MKS Group (Fig. 2). No participants were excluded after
randomization, and all randomised children were in-
cluded in the analysis. Groups did not differ regarding
the demographic data or characteristics of the dental
treatment sessions (Table 1). All children completed the
dental treatment as planned. The sedation level varied
among minimal, moderate and dissociative status.
Children’s behaviour, according to Houpt scale scores,
did not differ between the MK and MKS groups, con-
sidering the median scores for sleep, movement and cry
in the whole session (Fig. 3), or at specific times of dental
treatment (Table 2). For the majority of assessments, chil-
dren were awake, with absent or minimal crying, or move-
ment; overall behaviour was mostly good to very good. An
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Fig. 2 Flow diagram of the progress through the clinical trial phases
Table 1 Demographic data and characteristics of the dental treatment sessions of children
Variables n (%), mean (SD) or median (25%–75%) P
MK Group (n = 13) MKS Group (n = 14)
Gender (n) 0.28a
Male 10 (76.9%) 8 (57.1%)
Female 3 (23.1%) 6 (42.9%)
Age (years) 4.7 (0.6) 5.2 (0.8) 0.07b
Weight (kg) 16.5 (15.7–19.6) 19.6 (16.7–23.9) 0.18c
Dose of oral sedatives
Ketamine (mg) 48.6 (2.3) 48.4 (3.4) 0.54a
Midazolam (mg) 8.9 (1.2) 9.5 (3.1) 0.32b
Need of physical restraint
During administration of local anaesthesia 9 (69.2%) 8 (57.1%) 0.70a
During use of high-speed handpieced 7 (58.3%) 8 (57.1%) 0.86a
Dental procedure duration (min) 44.6 (8.2) 45.0 (6.3) 0.89b
Time for recovery (min) 84.7 (24.3) 72.2 (23.4) 0.23b




dHigh-speed handpiece was not used in one MK child because of severe uncooperativeness
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additional analysis was performed to compare the groups
and children presenting more negative scores (3 and 4) for
crying and movement; MKS children showed less hyster-
ical/continuous crying at the time of local anaesthesia
administration (Table 3). By plotting the evolution of the
children’s crying and movement during the dental session,
we observed that children in the MKS group tended to
show a smaller drop in Houpt scores (Fig. 4).
Oxygen saturation and pulse remained adequate
throughout the procedure and did not differ between
groups (Table 4).
Intraoperatively, the only one case of adverse event ob-
served and classified as minor risk was “failed sedation”,
i.e., the “inability to attain suitable conditions to humanely
perform the procedure” [20]: one girl from the MK group
had the dental treatment aborted after the administration
of local anaesthesia because of her severe uncooperative-
ness; she did receive a tooth restoration with glass iono-
mer cement instead of composite. Prolonged recovery
(Table 1) as well as serious adverse events, such as severe
drop oxygen saturation (<75% or <90% for more than
60 s), prolonged apnea (>60 s), cardiovascular shock or
Fig. 3 Behaviour scores according to Houpt scales comparing groups midazolam/ketamine (MK) and midazolam/ketamine/sevoflurane (MKS) (P > 0.05;
Mann-Whitney test)
Table 2 Houpt scores observed at different times of the dental treatment session while under sedation
Houpt Scores Median (25%–75%) Pa
MK Group (n = 13) MKS Group (n = 14)
Sleep
Administration of anaesthesia 2.0 (1.0–2.0) 2.0 (2.0–3.0) 0.26
Use of high-speed handpieceb 2.0 (1.3–2.0) 2.0 (2.0–2.3) 0.81
End of session 2.0 (1.5–2.0) 2.0 (2.0–2.0) 0.33
Movement
Administration of anaesthesia 3.0 (2.0–3.5) 4.0 (2.8–4.0) 0.69
Use of high speedb 3.0 (1.3–4.0) 3.5 (2.0–4.0) 0.50
End of session 4.0 (2.0–4.0) 4.0 (2.0–4.0) 0.12
Cry
Administration of anaesthesia 2.0 (2.0–4.0) 3.0 (3.0–4.0) 0.18
Use of high-speed handpieceb 2.5 (1.3–4.0) 3.5 (2.0–4.0) 0.45
End of session 3.0 (2.5–4.0) 4.0 (2.0–4.0) 0.10
MK midazolam-ketamine, MKS midazolam-ketamine-sevoflurane
aMann-Whitney’s U-Test
bHigh-speed handpiece was not used in one MK child because of severe uncooperativeness
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cardiac arrest/pulse absence were not observed. There
was no deep sedation at any time of evaluation.
Of the total sample, 51.9% (14 children) reported
adverse events in the 24 h after sedation including 10
MK children and 4 MKS children (P = 0.01, Likelihood-
Ratio Chi-square; effect size 0.3). The most frequently
observed adverse events were excessive drowsiness
(22.2%, 6 children) and vomiting (22.2%, 6 children).
Nausea was observed in 3 children (14.3%); more than
one adverse event may have been reported for the same
patient. Other adverse events observed in 24 h after sed-
ation included restlessness, dizziness, malaise, headache
and otalgia (data not shown). One MK child had vomiting
in the perioperative period. No children had to be hospi-
talized after discharge.
Discussion
The main finding of this study was that the addition of
inhaled sevoflurane to an oral midazolam/ketamine regi-
men did not improve the overall behaviour of the chil-
dren undergoing sedation for dental treatment (except
during local anaesthesia administration), but did result
in less minor adverse events than the oral regimen alone.
The present outcomes on sevoflurane sedation success
were less favorable than previous clinical trials [9, 10, 12];
methodological aspects should explain these differences
and will be discussed.
First, we did not associate sevoflurane to nitrous oxide as
others did previously [9, 10, 12]; nitrous oxide could add a
second gas effect to sevoflurane and improve sedation [21].
Second, both groups in the present study received an asso-
ciation of midazolam and ketamine, which has been proved
effective in moderate sedation in both pediatric and dental
settings [22, 23]. Other trials associated sevoflurane/nitrous
oxide with intravenous midazolam [10], or only compared
sevoflurane/nitrous oxide with nitrous oxide [9, 12]. Third,
the participants in our study were restricted to an age
range of 4–6 years old, whilst other trials included
older children ranging from 3–10 [9], 6–14 [10], and
6–15 [12] years old. The younger age range of children
in our study presented a cognitive development issue
that would hinder their cooperation with a moderate,
interactive sedation, compared with older children.
Fourth, we analysed the children’s behaviour minute by
minute throughout the dental session, however other
trials [9, 10, 12] considered the completion of dental
treatment as the main outcome.
In addition, there was a difference in sample size
between our study and the aforementioned trials. In one
trial, the sample size was 30 [12], whilst other two trials
included more than 400 [9] and approximately 700 chil-
dren [10]. As effect sizes observed in this study varied
from small to large, one cannot affirm that sevoflurane
does not improved children’s behaviour outcomes. On
the other side, our limited sample size was controlled in
respect to the procedure performed, the same type of
local anaesthesia, a single trained operator, use of cali-
brated observers for the main outcome (child behaviour),
and children within a limited age range with similar base-
line behaviour. Thus, future studies would benefit from
larger sample sizes and to control for potential bias
involved in a procedural sedation.
Nevertheless, children that did not receive sevoflurane
in this study showed more continuous/hysterical crying
during the local anaesthesia administration (P = 0.01,
large effect size). We speculate that sevoflurane could
have prevented pain from the injection. A trend was ob-
served in sustained control of behaviour in patients
using sevoflurane for sedation, comparing to those with-
out the drug. Other studies link increased effectiveness
at the completion of treatment with the addition of
sevoflurane for sedation [9, 10, 24].
Table 3 Hysterical/Continuous Cry and Violent/Continuous Movement at specific moments of the local anaesthesia, use of high
rotation and at the end of the procedure
Variables n (%) P Effect size (phi)
Group MK (n = 13) Group MKS (n = 14)
Hysterical/Continuous Cry
Administration of local anaesthesia 7 (53.8%) 1 (7.1%) 0.01a 0.5
Use of high speedc 5 out of 12 (41.7%) 5 (35.7%) 0.76b 0.2
End of session 5 (38.5%) 3 (21.4%) 0.42a 0.2
Violent/Continuous Movement
Administration of local anaesthesia 4 (30.8%) 1 (7.1%) 0.17a 0.3
Use of high speedc 4 out of 12 (33.3%) 2 (14.3%) 0.37a 0.2
End of session 4 (30.8%) 1 (7.1%) 0.17a 0.3
MK midazolam-ketamine, MKS midazolam-ketamine-sevoflurane
aFisher’s Exact-Test
bPearson’s Chi-Square
cHigh-speed handpiece was not used in one MK child because of severe uncooperativeness
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In this study, there was a need to raise the fraction of
inspired sevoflurane to levels greater than 1% in order to
obtain the final expired concentration approximately
0.3–0.4% as in the other study [25]. It is speculated that
the movement of the head of the child, the difficulty of
nasal mask seal, and the presence of mouth breathing
are factors involved in a possible dilution of the fraction
of inspired sevoflurane; factors that could have mini-
mised the benefit in behavioural control through the
addition of inhalational anaesthetic while under sedation.
Actually, the range of concentration for sevoflurane sed-
ation has not yet been defined, varying from 0.3% (of-
fered) [24] in dental sedation to 4.0% [26]. We used the
goal of 0.3% to 0.4% end tidal concentration. In this
group of children, sevoflurane used as a sedative was as-
sociated with minor adverse events in a few cases.
However, a device for its delivery outside the operating
room is not yet standardised [24]. The Anaesthetic Con-
serving Device (AnaConDa®) has being used to deliver
sevoflurane to sedate mechanically ventilated patients
through traqueal cannula [27–29]. In this study, sevo-
flurane was provided through a mask placed over the
nose; some authors used a nasal cannula [25] or the
same mask used to deliver nitrous oxide [9, 10, 30].
On the other hand, like another trial [12], we did not
find any serious adverse events associated with the use of
sevoflurane; besides, it did not associate with longer re-
covery or post-discharge readmission. Furthermore, there
was a higher incidence of adverse events in the group that
did not use sevoflurane. To the best of our knowledge, the
literature does not explain the beneficial effect of sevoflur-
ane in the postoperative period regarding the occurrence
of minor adverse events, and should be further investi-
gated in studies with larger samples and different settings.
This randomised clinical trial contributes to the evi-
dence for the efficacy of inhaled sevoflurane as a sedation
agent. Yet, the issues discussed indicate that there are still
limitations for extensive clinical use of sevoflurane in
paediatric anaesthesia. Furthermore, it should be empha-
sised that more complex sedation techniques, such as
sevoflurane sedation, should be performed in specialised
centres by experienced teams [10].
Conclusions
The addition of inhaled sevoflurane to an oral mixture of
midazolam and ketamine did not significantly improve
Table 4 Heart rate and oxygen saturation observed at different
times of the dental treatment session while under sedation







Reception (baseline) 96.4 (17.7) 94.3 (17.2) 0.77a
Administration of
anaesthesia
122.7 (28.6) 107.1 (22.3) 0.13a
Use of high speedc 125.2 (32.9) 124.6 (26.9) 0.96a
End of session 133.2 (25.9) 123.9 (24.7) 0.35a
Oxygen saturation (%)
Reception (baseline) 97.5 (95.3–98.0) 97.5 (96.3–98.0) 0.89b
Administration of
anaesthesia
99.0 (98.0–100) 100.0 (99.0–100) 0.12b
Use of high speedc 99.5 (97.3–100) 99.0 (98.0–100) 0.89b
End of session 100.0 (98.0–100) 99.0 (97.5–100) 0.42b




cHigh-speed handpiece was not used in one MK child because of
severe uncooperativeness
Fig. 4 Houpt scores for “Movement” and “Cry” during the dental
treatment sessions under sedation, according to the midazolam/
ketamine (MK) and midazolam/ketamine/sevoflurane (MKS) group
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overall young children’s cooperation with dental treat-
ment, except during the local anaesthetic administration.
There was a trend that children who received sevoflurane
cried and moved less than those who received oxygen.
Besides, the sevoflurane supplement did not cause more
adverse events.
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